It may need to be discontinued if tolerance develops, as increasing the dose may be linked to serious health risks
Tirzepatide's peak arrives earlier, at roughly two to six weeks, and is more sensitive to how quickly the dose is escalated
Post-approval safety issues arose for a third of novel drugs approved from 2001 through 2010, leading a small number to be pulled from the market and many more to be labeled with additional safety warnings, research shows
GLP-1 medications are not recommended during breastfeeding
It is crucial to keep your cholesterol levels down, lowering your risk for a heart attack and stroke
Many people on Ozempic, Wegovy, Mounjaro, or Zepbound are not just eating smaller meals